About Mater Private Cardiology
Clinical Trials at Mater Private Cardiology
During the past decade, Mater Private Cardiology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Mater Private Cardiology"
#1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Mater Private Cardiology
According to Clinical.Site data, the most researched conditions in "Mater Private Cardiology" are
"Castration-Resistant Prostate Cancer" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Mater Private Cardiology" in a lesser frequency.
Clinical Trials Intervention Types at Mater Private Cardiology
Most popular intervention types in "Mater Private Cardiology" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Enzalutamide" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Mater Private Cardiology
The vast majority of trials in "Mater Private Cardiology" are
2 trials for "Male" genders.
Clinical Trials Status at Mater Private Cardiology
Currently, there are NaN active trials in "Mater Private Cardiology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Mater Private Cardiology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Mater Private Cardiology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".